Study: TAVR outperforms surgery for aortic stenosis in patients with diabetes

12/2/2013 | MedPage Today (free registration)

Data on patients with diabetes who were treated for aortic stenosis revealed those who underwent transcatheter aortic valve replacement had lower rates of all-cause mortality and renal failure at one year than those treated with surgery, although the difference in mortality disappeared after two years. "[A] less invasive method of valve replacement that avoids the injurious effects of cardiopulmonary bypass may lead to improved clinical outcomes among these high-risk patients with diabetes," researchers wrote in the Journal of the American College of Cardiology.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY